ライフサイエンスコーパス: Mycobacterium avium complex

1 PLICOR MTB positive and culture positive for Mycobacterium avium complex.

2 ons, including Cladophialophora bantiana and Mycobacterium avium complex.

3 e closely related organisms and comprise the Mycobacterium avium complex.

4 46 children (10.8%); 45.7% of isolates were Mycobacterium avium complex.

5 rugs (1 case), documented contamination with Mycobacterium avium complex (1 case), suspected cross-co

6 l disease (mean number of organs infected by Mycobacterium avium complex 4.1 [SD 0.8] vs 2.0 [1.1], p

7 from 42 patients grew mycobacteria (58 grew Mycobacterium avium complex, 4 grew Mycobacterium kansas

8 The most common species recovered were Mycobacterium avium complex (69 isolates) and Mycobacter

9 Mycobacterium avium complex (72%) and Mycobacterium absc

10 (100%), CD4 cell count less than 200 (84%), Mycobacterium avium complex (73%), and Pneumocystis cari

11 Mycobacterium abscessus (34%) and Mycobacterium avium complex (83%) were the most common n

12 Nearly 60% of positive cultures were for Mycobacterium avium complex, although this ranged by sta

13 Among 1038 participants with pulmonary Mycobacterium avium complex and 120 with Mycobacterium a

14 73 (4.3%) were positive for mycobacteria (68 Mycobacterium avium complex and 5 M. tuberculosis).

15 One hundred isolates of Mycobacterium avium complex and eight M. simiae isolates

16 portunistic pathogens of HIV disease such as Mycobacterium avium complex and Pneumocystis carinii, we

17 , 14% (1/7) for Cryptococcus, 10% (1/10) for Mycobacterium avium complex, and 4% (3/72) for PCP.

18 ifferent Mycobacterium tuberculosis complex, Mycobacterium avium complex, and Mycobacterium spp. dire

19 ication and hybridization were observed with Mycobacterium avium complex- and/or Mycobacterium paratu

20 Members of the Mycobacterium avium complex are a family of bacteria tha

21 Pneumocystis carinii pneumonia, Mycobacterium avium complex bacteremia, cytomegalovirus,

22 ing the p35 gene hybridized only to DNA from Mycobacterium avium complex, but not to DNAs from other

23 Prophylaxis against Mycobacterium avium complex can safely be withdrawn or w

24 Mycobacterium avium complex cultures, CD4(+) cell counts

25 ttributable to cytomegalovirus retinitis and Mycobacterium avium complex declined over time (p=0.0058

26 HIV-infected patients with untreated Mycobacterium avium-complex diarrhea are associated with

27 Calif.) to detect Mycobacterium gordonae and Mycobacterium avium complex directly in liquid medium fl

28 Several agents are effective in preventing Mycobacterium avium complex disease in patients with adv

29 Risk of Mycobacterium avium complex disease was examined in huma

30 infections (Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus

31 Azithromycin is active in treating Mycobacterium avium complex disease, but it has not been

32 phylaxis versus withdrawal for prevention of Mycobacterium avium complex disease.

33 We report a case of recurrent disseminated Mycobacterium avium complex (DMAC) disease with anti-gam

34 g the pseudocording, or loose aggregation of Mycobacterium avium complex from M. tuberculosis and the

35 safety of discontinuing prophylaxis against Mycobacterium avium complex has been uncertain.

36 yelitis (patient 1) and disseminated CMV and Mycobacterium avium complex infection (patient 2), respe

37 IS event in HIV-infected patients, unmasking Mycobacterium avium complex infection after starting ant

38 y in which several members have disseminated Mycobacterium avium complex infection.

39 rganism can cause invasive disease mimicking Mycobacterium avium complex infection; recognition and i

40 The Mycobacterium avium complex is a source of disseminated

41 Infection with Mycobacterium avium complex is acquired from the environ

42 A major phenotypic trait of the Mycobacterium avium complex is the ability to produce ro

43 Disseminated infection with Mycobacterium avium complex is the most common opportuni

44 were evaluated for susceptibility testing of Mycobacterium avium complex isolates against clarithromy

45 inically significant isolates included eight Mycobacterium avium complex isolates and one each of Bar

46 ribosomal internal transcribed spacer of 56 Mycobacterium avium complex isolates from pediatric pati

47 g activities seem not to be risk factors for Mycobacterium avium complex lung disease in HIV-negative

48 Mycobacterium avium complex lung disease is an increasin

49 omponent of multidrug treatment regimens for Mycobacterium avium complex lung disease.

50 neumocystis jeroveci pneumonia, disseminated Mycobacterium avium complex, lymphoid interstitial pneum

51 Isolates (119) of the Mycobacterium avium complex (MAC) accounted for 67% of a

52 Whether infection with Mycobacterium avium complex (MAC) among patients with ac

53 e cases, 122 (64%) were culture-positive for Mycobacterium avium complex (MAC) and 69 (36%) for M. ab

54 Of 600 sets tested, 85 (14%) yielded Mycobacterium avium complex (MAC) and 9 (2%) yielded oth

55 In lymphoid tissues coinfected with Mycobacterium avium complex (MAC) and HIV-1, increased v

56 f 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex (MAC) and human dihydrofolat

57 PGE2 production by monocytes infected with Mycobacterium avium complex (MAC) and its effects on int

58 As we have shown for Mycobacterium avium complex (MAC) and Pneumocystis carin

59 NTM-D by Mycobacterium avium complex (MAC) and rapidly growing my

60 s developed for studying macrolide-resistant Mycobacterium avium complex (MAC) and to measure the eff

61 Members of the Mycobacterium avium complex (MAC) are characterized as n

62 Members of the Mycobacterium avium complex (MAC) are important environm

63 Mycobacterium avium complex (MAC) are opportunistic resp

64 re rates for pulmonary disease caused by the Mycobacterium avium complex (MAC) are poor.

65 To determine the relationship between Mycobacterium avium complex (MAC) bacteremia and HIV RNA

66 The relationship between Mycobacterium avium complex (MAC) bacteremia and proinfl

67 Patients with AIDS and Mycobacterium avium complex (MAC) bacteremia are at high

68 type 1-infected persons with newly diagnosed Mycobacterium avium complex (MAC) bacteremia were enroll

69 Eight AIDS patients with Mycobacterium avium complex (MAC) bacteremia were random

70 y virus type 1 (HIV-1)-infected persons with Mycobacterium avium complex (MAC) bacteremia, the levels

71 reproducibility of susceptibility testing of Mycobacterium avium complex (MAC) by broth microdilution

72 r antimycobacterial therapy for disseminated Mycobacterium avium complex (MAC) could be withdrawn fro

73 n alone and in combination for prevention of Mycobacterium avium complex (MAC) disease were compared

74 in is a major drug used for the treatment of Mycobacterium avium complex (MAC) disease, but standard

75 Among MSM, the most frequent OIs were Mycobacterium avium complex (MAC) disease, Pneumocystis

76 effective drug regimens for the treatment of Mycobacterium avium complex (MAC) disease.

77 Although opportunistic infections due to Mycobacterium avium complex (MAC) have been less common

78 determine the relationship between levels of Mycobacterium avium complex (MAC) in blood and tissues,

79 Persistent growth of Mycobacterium avium complex (MAC) in the lungs indicates

80 During the terminal stages of AIDS, Mycobacterium avium complex (MAC) infection is the most

81 Mycobacterium avium complex (MAC) infection is the most

82 The relationship between Mycobacterium avium complex (MAC) infection of blood and

83 s conducted in two trials of prophylaxis for Mycobacterium avium complex (MAC) infection to describe

84 ulted from unsuspected local or disseminated Mycobacterium avium complex (MAC) infection.

85 etic diversity and molecular epidemiology of Mycobacterium avium complex (MAC) infections in children

86 cumented history and continued prevalence of Mycobacterium avium complex (MAC) infections.

87 Mammals are generally resistant to Mycobacterium avium complex (MAC) infections.

88 The Mycobacterium avium complex (MAC) is a group of closely

89 The Mycobacterium avium complex (MAC) is an important cause

90 The Mycobacterium avium complex (MAC) is an important group

91 Lung disease caused by Mycobacterium avium complex (MAC) is increasing in preva

92 Rapid identification of Mycobacterium avium complex (MAC) is possible by use of

93 robiologic cure of AIDS-related disseminated Mycobacterium avium complex (MAC) is possible in patient

94 Mycobacterium avium complex (MAC) is the most common dis

95 debilitating pulmonary disease, among which Mycobacterium avium complex (MAC) is the most common spe

96 Mycobacterium avium complex (MAC) isolates among patient

97 features and outcome of macrolide-resistant Mycobacterium avium complex (MAC) lung disease are not k

98 in prospective macrolide treatment trials of Mycobacterium avium complex (MAC) lung disease were asse

99 household water sources for 36 patients with Mycobacterium avium complex (MAC) lung disease were eval

100 iven Monday, Wednesday, and Friday (TIW) for Mycobacterium avium complex (MAC) lung disease were init

101 cs and to evaluate relapses in patients with Mycobacterium avium complex (MAC) lung disease, but the

102 atment of noncavitary nodular bronchiectatic Mycobacterium avium complex (MAC) lung disease, supporti

103 Organisms within the Mycobacterium avium complex (MAC) may have differential

104 Mycobacterium avium complex (MAC) organisms cause dissem

105 The clinical significance of recovery of Mycobacterium avium complex (MAC) organisms from respira

106 Only 35.6%-50.8% of patients with Mycobacterium avium complex (MAC) pulmonary disease achi

107 The numbers of isolates of Mycobacterium avium complex (MAC) recovered were 172 (10

108 Species identification of isolates of the Mycobacterium avium complex (MAC) remains a difficult ta

109 DR (NTM-DR) line probe assay for identifying Mycobacterium avium complex (MAC) species and Mycobacter

110 Adherence of Mycobacterium avium complex (MAC) to human respiratory e

111 herapeutic outcome in patients infected with Mycobacterium avium complex (MAC) was evaluated.

112 Total mycobacteria and Mycobacterium avium complex (MAC) were quantified by qPC

113 Mycobacterium avium complex (MAC) were the dominant spec

114 Mycobacterium avium complex (MAC) within macrophages und

115 actors that contribute to protection against Mycobacterium avium complex (MAC), cytokine production b

116 spp., nontuberculous mycobacteria (NTM), and Mycobacterium avium complex (MAC), however, were widespr

117 nterleukin (IL)-7 on intracellular growth of Mycobacterium avium complex (MAC), human macrophages wer

118 ulous mycobacteria, including members of the Mycobacterium avium complex (MAC), M. smegmatis, and M.

119 genetically similar to other members of the Mycobacterium avium complex (MAC), some of which are non

120 y (HAART) on cell-mediated immunity (CMI) to Mycobacterium avium complex (MAC), we measured immune re

121 ies causing pulmonary disease are members of Mycobacterium avium complex (MAC).

122 The most common species recovered were Mycobacterium avium complex (MAC, 73 isolates) and Mycob

123 Organisms in the Mycobacterium avium complex (MAC; M. avium, M. intracell

124 tory pulmonary nontuberculous mycobacterial (Mycobacterium avium complex [MAC] or Mycobacterium absce

125 tis carinii pneumonia [PCP] and disseminated Mycobacterium avium-complex [MAC] infection) in persons

126 ow-growing species, including members of the Mycobacterium avium complex (MAVC).

127 tivity against multiple clinical isolates of Mycobacterium avium complex (MIC's = 0.5-4 micrograms/mL

128 s with Emberger syndrome, monocytopenia with Mycobacterium avium complex (MonoMAC), and MDS.

129 sed by the most common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and

130 mocystis carinii (n = 26), bacteria (n = 3), Mycobacterium avium complex (n = 2), Nocardia sp. (n = 1

131 Infections caused by organisms of the Mycobacterium avium complex occur in approximately 50 to

132 ia, esophageal candidiasis, and disseminated Mycobacterium avium complex or Mycobacterium kansasii in

133 Ten of 639 MGIT cultures grew Mycobacterium avium complex or Mycobacterium kansasii, h

134 hose previously treated for tuberculosis and Mycobacterium avium complex predominated (27.7% [95% CI:

135 Mycobacterium avium complex pulmonary disease (MAC-PD) i

136 new therapy for Candida esophagitis, whereas Mycobacterium avium complex therapy may be discontinued

137 odes), herpes simplex virus (four episodes), Mycobacterium avium complex (two episodes), and M tuberc

138 Mycobacterium avium complex was concomitantly isolated i

139 c broth dilution test method recommended for Mycobacterium avium complex was modified to develop a re

140 Mycobacterium avium complex was seen in 75% of NTM-posit

141 99 NTM cases were reported (PNTM: 231, 77%); Mycobacterium avium complex was the most common species

142 Mycobacterium avium complex was the most frequently isol

143 Isolates of the Mycobacterium avium complex were examined for hemolysin

144 ailable nucleic-acid probes specific for the Mycobacterium avium complex were unreactive for these st